REGINA FRANCO: Open Payments
NPI 1780680116 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 7 payments from 7 companies in 2025. Trend: 2023 $333 · 2024 $709 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $137 |
| Genmab U.S., Inc. | 1 | $123 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $113 |
| Medtronic, Inc. | 1 | $86 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
Products named: FREESTYLE LIBRE 3, Tivdak, OPDIVO, Trodelvy, Wegovy, CLOSUREFAST, ENHERTU.
Industry payments across SC — which companies pay providers there.
